<DOC>
	<DOCNO>NCT00794638</DOCNO>
	<brief_summary>The purpose study assess safety SyB L-0501 combination Rituximab patient aggressive B-cell non-Hodgkin 's lymphoma , explore recommend dose Phase II clinical trial .</brief_summary>
	<brief_title>A Phase I Clinical Trial Assess Safety SyB L-0501 Combination With Rituximab Patients With Aggressive B-cell Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Aggressive Bcell nonHodgkin 's lymphoma patient prior therapy satisfy condition list . No restriction regard gender . Patients follow histologically confirm CD20 ( + ) Bcell nonHodgkin 's lymphoma : 1 . Diffuse large Bcell lymphoma 2 . Mantle cell lymphoma 3 . Transformed lymphoma 4 . Follicular lymphoma ( Grade 3 ) Fail CR prior chemotherapy , relapse follow CR recurrence follow PR . Patients judge carry effect prior therapy ( cancer chemotherapy , antibody therapy radiation/ radiotherapy . Patients age 20 75 year time inform consent obtain Patients adequately maintain organ function ( e.g. , bone marrow , heart , lung , liver , kidney function ) Patients hospitalize first cycle Patients capable personally give voluntary informed consent write participate study Patients meet follow criterion exclude . Patients serious complication ( hepatic renal failure ) Patients complication medical history serious cardiac disease ( e.g. , myocardial infarction , ischemic heart disease ) Patients serious gastrointestinal symptom ( e.g. , severe nausea , vomit , diarrhea ) Patients positive HBs antigen , HCV antibody , HIV antibody Patients receive investigational drug unapproved medication within 3 month registration study Patients history hematopoietic stem cell transplantation radioimmunotherapy Patients pregnant , childbearing potential , lactating Patients , whether male female , agree contraception Patients otherwise judge investigator sub investigator unsuitable</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Diffuse Large B-Cell Lymphoma</keyword>
	<keyword>Mantle cell Lymphoma</keyword>
	<keyword>Transformed lymphoma , transform diffuse large B-cell lymphoma</keyword>
	<keyword>Follicular Lymphoma</keyword>
</DOC>